The nation of Zimbabwe has turned down a substantial American health deal valued at $367m (272 million pounds) over five years because of the United States' insistence on sensitive biological samples.
This rejection came to light after a official document dated December was disclosed, which showed President Emmerson Mnangagwa believed the arrangement was "lopsided".
A government representative later explained that the US was requesting health data for scientific study and commercial gain but was not willing to share the resulting advantages from future medical innovations.
"We are forced to start the difficult and regrettable task of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for further dialogue to find a agreement acceptable to both sides so the nation's critical HIV programme can continue.
Wider Background
This development follows a similar situation in neighbouring Kenya, where a court halted a similar health funding agreement following legal challenges were raised about the safety of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
USAID had overseen aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to enhance openness and accountability.
According to reports, 16 nations in Africa have to date signed similar agreements, constituting over $18.3bn of fresh investment.
Details of the Rejected Agreement
This assistance for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation would have delivered immense advantages for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy via American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, with no equivalent promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"Put simply, our country would provide the basic resources for medical research without any assurance that the resulting innovations would be accessible to our citizens should a future health crisis emerge."
Sovereignty and Global Health
Mangwana further noted that the American exit from the global health body and its pursuit of bilateral deals were upending frameworks already established through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing system created to deal with potential global health emergencies.
"This system is designed to guarantee that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to create them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We are open to further dialogue with our US partners on how subsequent collaboration could be designed in a manner that honours the sovereignty and dignity of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but recommended that talks need to persist considering much of the nation's HIV programmes relied on international support.
"Where specific concerns exist, including those relating to information security or implementation frameworks, these can often be resolved via detailed discussion and negotiated safeguards," the group added.
This impasse highlights the continuing challenges between accepting much-needed international aid and safeguarding national sovereignty in an increasingly interconnected world.